Consultant Virologist at UKHSA. Respiratory and enteric viruses / transmission / human challenge / public health.
Joined January 2010
- Tweets248
- Following602
- Followers208
- Likes335
Anika Singanayagam retweeted
US - California: CDPH statement - 3rd #H5N1 confirmed human case confirmed by the CDC. + 2 more possible cases identified with CDC tests pending. All are animal contact, mild symptoms. flutrackers.com/forum/forum/… h/t Commonground
Anika Singanayagam retweeted
Doses of an experimental #Marburg vaccine — designed at the @NIH's Vaccine Research Center & being developed by @sabinvaccine — arrived in Rwanda on Saturday where a clinical trial will soon get underway. Photo: Sabin Institute statnews.com/2024/10/04/marb…
Anika Singanayagam retweeted
@mvankerkhove of @WHO urging for evidence driven policy, equitable access to safe and effective vaccines, building Pandemic Influenza Preparedness (PIP) strategy, and platforms to facilitate sharing of key reagents
Anika Singanayagam retweeted
Do we need more women in #pathology mentoring and leadership? Ann Gronowski believes we do, and here’s why 💭 bit.ly/3vuIJYr
Anika Singanayagam retweeted
An important study by F. Eun-Hyung Lee's team shows that long lived plasma cells (the source of long-term circulating antibodies) fail to establish after mRNA vaccination (even combined with SARS-CoV-2 infection). 🧵 (1/)
nature.com/articles/s41591-0…
Anika Singanayagam retweeted
Why are some people volunteering to be infected with diseases?
Dr @anikasinga from @ImperialInfect shares preliminary insights and findings on the SARS-CoV-2 human challenge study with @BBCNews
#COVID19
bbc.com/future/article/20240…
Anika Singanayagam retweeted
Clinicians detail H5N1 infections in 2 Michigan farm workers
One patient had conjunctivitis in one eye, and the other had longer lasting flulike symptoms.
ow.ly/laZi50SUc1Y
Anika Singanayagam retweeted
MSC has published its findings on the 2023 clinical academic survey, revealing an ageing workforce and continuing gender and ethnic imbalances in clinical academia.
Press release: bit.ly/3vGqZJU
Interactive tool: bit.ly/3JsxwMM
Anika Singanayagam retweeted
3rd US #H5N1 #birdflu case, this one with respiratory symptoms. Farm worker in Michigan who wasn't wearing PPE. Said to be recovering. statnews.com/2024/05/30/bird…
Anika Singanayagam retweeted
To further protect the U.S. livestock industry from the threat posed by highly pathogenic H5N1 avian influenza, @USDA is sharing a number of actions that we are taking with our federal partners to help us get ahead of this disease and limit its spread. usda.gov/media/press-release…
Anika Singanayagam retweeted
LAST CHANCE!📢
We are looking for healthy volunteers to take part in our COVID-19 Human Challenge study.
If you are 18-30yrs, have been vaccinated against COVID-19 and in good health, visit: imperial.ac.uk/infectious-di…. You will be paid up to £4,500 for your time and inconvenience.
Anika Singanayagam retweeted
A new review highlights how T cells could play a crucial role in protecting us from emerging COVID-19 variants. 🦠
The study by Prof @Daltmann10 and Prof @BoytonRosemary suggests. T cells are more robust against ‘Omicron breakthroughs’ than antibodies.👇
imperial.ac.uk/news/251476/c…
Anika Singanayagam retweeted
Thank you to all the families who took part in the HARMONIE trial which showed nirsevimab could reduce hospitilisations due to RSV by 83% in a trial that was done in near real-life situations @NIHRresearch @UHSFTresearch @UoS_Medicine @southamptonCRF @NIHRCRNWessex
Anika Singanayagam retweeted
Our new issue is available
Take a look 👉🏾bit.ly/EUS2839
Topics include
#influenza #flu #SARSCoV2 #COVID19 #CovidVaccines #outbreaks #enterovirus #HAI #AMR #AntimicrobialResistance #children #publichealth
Anika Singanayagam retweeted
The two papers on the #H5N1 avian influenza outbreak in cats in Poland make for really interesting reading. The first describes the outbreak and the second investigates the emergence and transmission.
(I'm on a train again so a brief thread).
Anika Singanayagam retweeted
Our @anikasinga commented in @Nature on findings which show that a small proportion of individuals with COVID-19 have the potential to be highly infectious.
The study examined how the virus spreads from the nose to the immediate surroundings.👇
nature.com/articles/d41586-0…
Anika Singanayagam retweeted
🆕 @LancetMicrobe
Rigorous tracking of #SARSCoV2 challenge study
—importance of the nose as the portal and airborne transmission
—recovery of viable virus on surfaces
—2 superspreader individuals emitted ~86% of airborne virus
thelancet.com/journals/lanmi… @wendybarclay11 + colleagues
Anika Singanayagam retweeted
New research article>
Viral emissions into the air and environment after #SARSCoV2 human challenge: a phase 1, open label, first-in-human study
thelancet.com/journals/lanmi…
#COVID19
Anika Singanayagam retweeted
'Mucosal vaccines have the potential to dramatically reduce transmission of COVID-19, and warrant investment of resources, focus and coordination.'
Read the full report of our workshop in partnership with @NIAIDNews, @wellcometrust @gatesfoundation 👇
rdcu.be/c9IBj
Anika Singanayagam retweeted
The biases in scientific publishing during the pandemic damaged women’s visibility, recognition, and career advancement, reports @jocalynclark bmj.com/content/381/bmj.p788
